Active Ingredient: DARIFENACIN HYDROBROMIDE
Proprietary Name: DARIFENACIN HYDROBROMIDE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: EQ 7.5MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211045
Product Number: 001
Approval Date: Jan 6, 2020
Applicant Holder Full Name: POLYGEN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information